Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Back

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Molecules and Cells|June 13, 2000
Cloning of a sesquiterpene cyclase and its functional expression by domain swapping strategyK Back, J Nah, S B Lee, et al.
AIDS Research and Human Retroviruses|September 1, 1997
Structural and functional analysis of negatively charged milk proteins with anti-HIV activityB Berkhout, G C Derksen, N K Back, et al.
International Journal of Pharmaceutics|August 21, 2016
Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCASA-L Lainé, D Price, J Davis, et al.
Neuroscience Letters|July 6, 2000
Role of signals from the dorsal root ganglion in neuropathic pain in a rat modelH S Na, K H Ko, S K Back, et al.
Virology|March 1, 1994
An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralizationN K Back, L Smit, J J De Jong, et al.
Genes, Brain, and Behavior|April 6, 2007
Markedly attenuated acute and chronic pain responses in mice lacking adenylyl cyclase-5K-S Kim, J Kim, S K Back, et al.
AIDS (London, England)|March 14, 2000
In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitorsN K Back, A van Wijk, D Remmerswaal, et al.
Archives of Virology|January 1, 1992
Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1J P Langedijk, N K Back, E Kinney-Thomas, et al.
Neuroreport|February 24, 2001
Decrease in spinal CGRP and substance P is not related to neuropathic pain in a rat modelH S Na, H J Kim, B Sung, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assayC A Boucher, W Keulen, T van Bommel, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Molecules and Cells|June 13, 2000
Cloning of a sesquiterpene cyclase and its functional expression by domain swapping strategyK Back, J Nah, S B Lee, et al.
AIDS Research and Human Retroviruses|September 1, 1997
Structural and functional analysis of negatively charged milk proteins with anti-HIV activityB Berkhout, G C Derksen, N K Back, et al.
International Journal of Pharmaceutics|August 21, 2016
Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCASA-L Lainé, D Price, J Davis, et al.
Neuroscience Letters|July 6, 2000
Role of signals from the dorsal root ganglion in neuropathic pain in a rat modelH S Na, K H Ko, S K Back, et al.
Virology|March 1, 1994
An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralizationN K Back, L Smit, J J De Jong, et al.
Genes, Brain, and Behavior|April 6, 2007
Markedly attenuated acute and chronic pain responses in mice lacking adenylyl cyclase-5K-S Kim, J Kim, S K Back, et al.
AIDS (London, England)|March 14, 2000
In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitorsN K Back, A van Wijk, D Remmerswaal, et al.
Archives of Virology|January 1, 1992
Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1J P Langedijk, N K Back, E Kinney-Thomas, et al.
Neuroreport|February 24, 2001
Decrease in spinal CGRP and substance P is not related to neuropathic pain in a rat modelH S Na, H J Kim, B Sung, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assayC A Boucher, W Keulen, T van Bommel, et al.
Pageof 5